SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-24-138722
Filing Date
2024-12-19
Accepted
2024-12-19 21:55:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 26345
2 EX-99.13 ck0000888721-ex99_13.htm EX-99.13 211289
3 EX-99.14 ck0000888721-ex99_14.htm EX-99.14 342422
4 EX-99.15 ck0000888721-ex99_15.htm EX-99.15 42185
5 EX-99.16 ck0000888721-ex99_16.htm EX-99.16 11104
6 EX-99.A ck0000888721-ex99_a.pdf EX-99.A 214395
  Complete submission text file 0000950170-24-138722.txt   930567
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Subject) CIK: 0000888721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-44122 | Film No.: 241564880
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 85 ORCHARD ROAD SKILLMAN NJ 08558
Business Address 85 ORCHARD ROAD SKILLMAN NJ 08558 8464705596
MiCo IVD Holdings, LLC (Filed by) CIK: 0001952094 (see all company filings)

IRS No.: 881399456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A